In summary, our present study demonstrated for the first time that B-Myb is aberrantly overexpressed in NSCLC and that B-Myb promotes lung cancer cell growth both in vitro and in vivo. The gene discussed is MYBL2; the disease is non-small cell lung carcinoma.